156 related articles for article (PubMed ID: 9526568)
1. Orally active antimalarial 3-substituted trioxanes: new synthetic methodology and biological evaluation.
Posner GH; Cumming JN; Woo SH; Ploypradith P; Xie S; Shapiro TA
J Med Chem; 1998 Mar; 41(6):940-51. PubMed ID: 9526568
[TBL] [Abstract][Full Text] [Related]
2. A short synthesis and biological evaluation of potent and nontoxic antimalarial bridged bicyclic beta-sulfonyl-endoperoxides.
Bachi MD; Korshin EE; Hoos R; Szpilman AM; Ploypradith P; Xie S; Shapiro TA; Posner GH
J Med Chem; 2003 Jun; 46(12):2516-33. PubMed ID: 12773055
[TBL] [Abstract][Full Text] [Related]
3. Antimalarial simplified 3-aryltrioxanes: synthesis and preclinical efficacy/toxicity testing in rodents.
Posner GH; Jeon HB; Parker MH; Krasavin M; Paik IH; Shapiro TA
J Med Chem; 2001 Sep; 44(19):3054-8. PubMed ID: 11543673
[TBL] [Abstract][Full Text] [Related]
4. Orally active, water-soluble antimalarial 3-aryltrioxanes: short synthesis and preclinical efficacy testing in rodents.
Posner GH; Jeon HB; Ploypradith P; Paik IH; Borstnik K; Xie S; Shapiro TA
J Med Chem; 2002 Aug; 45(18):3824-8. PubMed ID: 12190305
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and in vitro cancer cell growth inhibition evaluation and antimalarial testing of trioxanes installed in cyclic 2-enoate substructures.
Hossain MI; Świtalska M; Peng W; Takashima M; Wang N; Kaiser M; Wietrzyk J; Dan S; Yamori T; Inokuchi T
Eur J Med Chem; 2013 Nov; 69():294-309. PubMed ID: 24056020
[TBL] [Abstract][Full Text] [Related]
6. Exploiting a basic chemosensitizing pharmacophore hypothesis. Part 1: synthesis and biological evaluation of novel arylbromide and bicyclic chemosensitizers against drug-resistant malaria parasites.
Chouteau F; Ramanitrahasimbola D; Rasoanaivo P; Chibale K
Bioorg Med Chem Lett; 2005 Jun; 15(12):3024-8. PubMed ID: 15908208
[TBL] [Abstract][Full Text] [Related]
7. Malaria-infected mice are cured by a single dose of novel artemisinin derivatives.
Posner GH; Paik IH; Chang W; Borstnik K; Sinishtaj S; Rosenthal AS; Shapiro TA
J Med Chem; 2007 May; 50(10):2516-9. PubMed ID: 17439113
[TBL] [Abstract][Full Text] [Related]
8. Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles.
Zhang YK; Plattner JJ; Freund YR; Easom EE; Zhou Y; Ye L; Zhou H; Waterson D; Gamo FJ; Sanz LM; Ge M; Li Z; Li L; Wang H; Cui H
Bioorg Med Chem Lett; 2012 Feb; 22(3):1299-307. PubMed ID: 22243961
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of lactone ring-opened analogs of the antimalarial 1,2,4-trioxane artemisinin.
Posner GH; McGarvey DJ; Oh CH; Kumar N; Meshnick SR; Asawamahasadka W
J Med Chem; 1995 Feb; 38(4):607-12. PubMed ID: 7861408
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, derivatization, and structure-activity relationships of simplified, tricyclic, 1,2,4-trioxane alcohol analogues of the antimalarial artemisinin.
Cumming JN; Wang D; Park SB; Shapiro TA; Posner GH
J Med Chem; 1998 Mar; 41(6):952-64. PubMed ID: 9526569
[TBL] [Abstract][Full Text] [Related]
11. Extraordinarily potent antimalarial compounds: new, structurally simple, easily synthesized, tricyclic 1,2,4-trioxanes.
Posner GH; Oh CH; Gerena L; Milhous WK
J Med Chem; 1992 Jun; 35(13):2459-67. PubMed ID: 1619620
[TBL] [Abstract][Full Text] [Related]
12. Antimalarial activity of yingzhaosu A analogues.
Kim HS; Begum K; Ogura N; Wataya Y; Tokuyasu T; Masuyama A; Nojima M; McCullough KJ
J Med Chem; 2002 Oct; 45(21):4732-6. PubMed ID: 12361400
[TBL] [Abstract][Full Text] [Related]
13. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.
O'Neill PM; Rawe SL; Borstnik K; Miller A; Ward SA; Bray PG; Davies J; Oh CH; Posner GH
Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antimalarial activity of trioxaquine derivatives.
Dechy-Cabaret O; Benoit-Vical F; Loup C; Robert A; Gornitzka H; Bonhoure A; Vial H; Magnaval JF; Séguéla JP; Meunier B
Chemistry; 2004 Apr; 10(7):1625-36. PubMed ID: 15054749
[TBL] [Abstract][Full Text] [Related]
15. Orally active 1,2,4-trioxanes: synthesis and antimalarial assessment of a new series of 9-functionalized 3-(1-arylvinyl)-1,2,5-trioxaspiro[5.5]undecanes against multi-drug-resistant plasmodium yoelii nigeriensis in mice.
Singh C; Malik H; Puri SK
J Med Chem; 2006 May; 49(9):2794-803. PubMed ID: 16640340
[TBL] [Abstract][Full Text] [Related]
16. Orally active, hydrolytically stable, semisynthetic, antimalarial trioxanes in the artemisinin family.
Posner GH; Parker MH; Northrop J; Elias JS; Ploypradith P; Xie S; Shapiro TA
J Med Chem; 1999 Jan; 42(2):300-4. PubMed ID: 9925735
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Biological Evaluation of Novel 1,2,4-Trioxanes as Potential Antimalarial Agents.
Gupta AK; Varshney K; Kumar V; Srivastava K; Pant AB; Puri SK; Saxena AK
Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28207169
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antimalarial assessment of a new series of orally active amino-functionalized spiro 1,2,4-trioxanes.
Singh C; Hassam M; Naikade NK; Verma VP; Singh AS; Puri SK
J Med Chem; 2010 Nov; 53(21):7587-98. PubMed ID: 20936847
[TBL] [Abstract][Full Text] [Related]
19. Antimalarial activity of novel 1,2,5,6-tetraoxacycloalkanes and 1,2,5-trioxacycloalkanes.
Kim HS; Begum K; Ogura N; Wataya Y; Nonami Y; Ito T; Masuyama A; Nojima M; McCullough KJ
J Med Chem; 2003 May; 46(10):1957-61. PubMed ID: 12723958
[TBL] [Abstract][Full Text] [Related]
20. Orally active amino functionalized antimalarial 1,2,4-trioxanes.
Singh C; Malik H; Puri SK
Bioorg Med Chem Lett; 2004 Jan; 14(2):459-62. PubMed ID: 14698181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
